Dr. Anekonda received a doctoral degree from the University of California (UC) at Berkeley, postdoctoral training from the UC Davis, and Alzheimer disease and retinopathy related research experiences from the Oregon Health and Science University (OHSU) at Portland, Oregon. He currently serves as Assistant Professor in the Department of Neurology at OHSU. The long-term goal of his research is to define the neuroprotective mechanisms of herbal and non-herbal drugs at molecular and cellular levels and determine their treatment options for Alzheimer disease. The molecular pathways downstream of beta amyloid production are of particular interest: intracellular calcium, tau pathology, antiaging sirt1 and autophagy. Dr. Anekonda received a doctoral degree from the University of California (UC) at Berkeley, postdoctoral training from the UC Davis, and Alzheimer disease and retinopathy related research experiences from the Oregon Health and Science University (OHSU) at Portland, Oregon. He currently serves as Assistant Professor in the Department of Neurology at OHSU. The long-term goal of his research is to define the neuroprotective mechanisms of herbal and non-herbal drugs at molecular and cellular levels and determine their treatment options for Alzheimer disease. The molecular pathways downstream of beta amyloid production are of particular interest: intracellular calcium, tau pathology, antiaging sirt1 and autophagy.

Neuroprotective mechanisms by herbal and non-herbal drugs against Alzheimer′s disease pathology. Age-related neurodegeneration; beta amyloid and tau pathology; autophagy pathway; mitochondrial functions; anti-aging sirtuin and anti-inflammatory pathways; mechanisms of calorie restriction (CR) and CR mimetics (CRMs); in vitro and in vivo models of Alzheimer’s disease.